Motorika Medical (USA) Inc., headquartered in the United States, is a pioneering force in the medical technology industry, specialising in advanced rehabilitation solutions. Founded in 2010, the company has made significant strides in developing robotic rehabilitation systems that enhance patient recovery and mobility. With a focus on innovative products such as the Armeo and the ReoGo, Motorika stands out for its commitment to integrating cutting-edge robotics with user-friendly interfaces, ensuring effective therapy for patients with neurological conditions. The company operates primarily in North America and has established a strong market position, recognised for its contributions to improving rehabilitation outcomes. Motorika's dedication to research and development has led to notable achievements, positioning it as a leader in the field of robotic rehabilitation technology.
How does Motorika Medical (USA) Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Motorika Medical (USA) Inc.'s score of 3 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Motorika Medical (USA) Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. As a result, it is unclear what specific climate commitments or initiatives Motorika Medical has undertaken to address carbon emissions. The lack of emissions data and reduction initiatives suggests that the company may still be in the early stages of developing a comprehensive climate strategy. In the broader context of the medical technology industry, many companies are increasingly focusing on sustainability and carbon reduction, often setting science-based targets to align with global climate goals. However, without specific data or commitments from Motorika Medical, it is difficult to assess their position within this evolving landscape.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Motorika Medical (USA) Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

